subscribeSubscribe
Mylan`s Generic Lopinavir and Ritonavir Receives Approval in the U.S.

Mylan`s Generic Lopinavir and Ritonavir Receives Approval in the U.S.
FDA
07 Feb 2024
Share Share
Cipla, DNDi launch 4-in-1 antiretroviral treatment for young children with HIV

Cipla, DNDi launch 4-in-1 antiretroviral treatment for young children with HIV
EXPRESS PHARMA
14 Jun 2022
Share Share
Laurus` Generic Lopinavir & Ritonavir Receives Approval in the U.S.

Laurus` Generic Lopinavir & Ritonavir Receives Approval in the U.S.
FDA
21 Mar 2022
Share Share
A giant trial of COVID-19 treatments is restarting

A giant trial of COVID-19 treatments is restarting
Kai Kupferschmidt SCIENCEMAG
06 Aug 2021
Share Share
Hetero Labs Ltd Iii`s Generic Lopinavir; Ritonavir Receives Approval In US

Hetero Labs Ltd Iii`s Generic Lopinavir; Ritonavir Receives Approval In US
FDA
04 Jun 2021
Share Share
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
NEJM
03 Dec 2020
Share Share
Repurposed drugs not effective treatment for hospitalised COVID-19, WHO says

Repurposed drugs not effective treatment for hospitalised COVID-19, WHO says
Victoria Rees EUROPEANPHARMACEUTICALSREVIEW
20 Oct 2020
Share Share
Gilead refutes WHO’s claim over remdesivir’s efficacy

Gilead refutes WHO’s claim over remdesivir’s efficacy
Kim Yun-mi KOREABIOMED
19 Oct 2020
Share Share
Gilead’s COVID-19 drug Veklury falls short in WHO’s global trial

Gilead’s COVID-19 drug Veklury falls short in WHO’s global trial
Richard Staines PHARMAPHORUM
16 Oct 2020
Share Share
Pharming announces enrolment of first patient in multinational trial RUCONEST®

Pharming announces enrolment of first patient in multinational trial RUCONEST®
PRNEWSWIRE
10 Aug 2020
Share Share